 | • レポートコード：QYR9NV16652 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のオキシカルバゼピン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。オキシカルバゼピンの種類別には、錠剤（150mg、300mg、600mg）、経口懸濁液に、用途別には、小児用（2-4歳、4-16歳）、成人用に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・オキシカルバゼピンの種類別市場規模：錠剤（150mg、300mg、600mg）、経口懸濁液 ・オキシカルバゼピンの用途別市場規模：小児用（2-4歳、4-16歳）、成人用 ・オキシカルバゼピンの地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Novartis (Trileptal)、Supernus Pharmaceuticals (Oxtellar XR)、Sun Pharm、Ranbaxy Pharmaceuticals、Jubilant Generics、Taro Pharmaceuticals、Mylan、Stada Group、Glenmark Pharmaceuticals、ANI Pharmaceuticals、Teva Pharmaceutical、Roxane Laboratories、Nobelpharma、Apotex、Nexgen pharma、Amneal Pharmaceuticals、Hikma Pharmaceuticals、Jamp Pharma、Neuraxpharm、Orion Corporation、Sihuan Pharm、Humanwell Healthcare、Huikang Pharmaceutical ・市場規模予測2019-2025：生産量 ・市場規模予測2019-2025：消費量 ・バリューチェーン・販売チャネル分析 ・市場機会・課題分析 ... |
Oxcarbazepine, sold under the brand name Trileptal among others, is a medication used to treat epilepsy and bipolar disorder. It is a structural derivative of carbamazepine, with an extra oxygen atom to the benzylcarboxamide group. The presence of an extra oxygen atom in the structure reduces the susceptibility of the drug to hepatic metabolism, leading to prolonged pharmacological action or half life of the drug. In 2018, the global Oxcarbazepine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Oxcarbazepine.
This study researches the market size of Oxcarbazepine, presents the global Oxcarbazepine sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Oxcarbazepine in key regions like North America, Europe, China and India, presents sales, revenue, market share, growth rate of Oxcarbazepine for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.
This report includes the following manufacturers; we can also add the other companies as you want.
Supernus Pharmaceuticals (Oxtellar XR)
Sun Pharm
Ranbaxy Pharmaceuticals
Jubilant Generics
Taro Pharmaceuticals
Mylan
Stada Group
Glenmark Pharmaceuticals
ANI Pharmaceuticals
Teva Pharmaceutical
Roxane Laboratories
Nobelpharma
Apotex
Nexgen pharma
Amneal Pharmaceuticals
Hikma Pharmaceuticals
Jamp Pharma
Neuraxpharm
Orion Corporation
Sihuan Pharm
Humanwell Healthcare
Huikang Pharmaceutical
Market Segment by Product Type
Tablets (150mg, 300mg, 600mg)
Oral Suspension
Market Segment by Application
Pediatric Use (Aged 2-4 years, 4-16 years)
Adult Use
Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives are:
To analyze and research the global Oxcarbazepine status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Oxcarbazepine manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Oxcarbazepine are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Oxcarbazepine Market Size Growth Rate by Type
1.3.2 Tablets (150mg, 300mg, 600mg)
1.3.3 Oral Suspension
1.4 Market Segment by Application
1.4.1 Global Oxcarbazepine Market Share by Application (2019-2025)
1.4.2 Pediatric Use (Aged 2-4 years, 4-16 years)
1.4.3 Adult Use
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oxcarbazepine Market Size
2.1.1 Global Oxcarbazepine Revenue 2014-2025
2.1.2 Global Oxcarbazepine Sales 2014-2025
2.2 Oxcarbazepine Growth Rate by Regions
2.2.1 Global Oxcarbazepine Sales by Regions 2014-2019
2.2.2 Global Oxcarbazepine Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Oxcarbazepine Sales by Manufacturers
3.1.1 Oxcarbazepine Sales by Manufacturers 2014-2019
3.1.2 Oxcarbazepine Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Oxcarbazepine Revenue by Manufacturers (2014-2019)
3.2.2 Oxcarbazepine Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Oxcarbazepine Market Concentration Ratio (CR5 and HHI)
3.3 Oxcarbazepine Price by Manufacturers
3.4 Key Manufacturers Oxcarbazepine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Oxcarbazepine Market
3.6 Key Manufacturers Oxcarbazepine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Tablets (150mg, 300mg, 600mg) Sales and Revenue (2014-2019)
4.1.2 Oral Suspension Sales and Revenue (2014-2019)
4.2 Global Oxcarbazepine Sales Market Share by Type
4.3 Global Oxcarbazepine Revenue Market Share by Type
4.4 Oxcarbazepine Price by Type
5 Market Size by Application
5.1 Overview
5.1 Global Oxcarbazepine Sales by Application
6 North America
6.1 North America Oxcarbazepine Breakdown Data by Company
6.2 North America Oxcarbazepine Breakdown Data by Type
6.3 North America Oxcarbazepine Breakdown Data by Application
6.4 North America Oxcarbazepine Breakdown Data by Countries
6.4.1 North America Oxcarbazepine Sales by Countries
6.4.2 North America Oxcarbazepine Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
7 Europe
7.1 Europe Oxcarbazepine Breakdown Data by Company
7.2 Europe Oxcarbazepine Breakdown Data by Type
7.3 Europe Oxcarbazepine Breakdown Data by Application
7.4 Europe Oxcarbazepine Breakdown Data by Countries
7.4.1 Europe Oxcarbazepine Sales by Countries
7.4.2 Europe Oxcarbazepine Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oxcarbazepine Breakdown Data by Company
8.2 Asia Pacific Oxcarbazepine Breakdown Data by Type
8.3 Asia Pacific Oxcarbazepine Breakdown Data by Application
8.4 Asia Pacific Oxcarbazepine Breakdown Data by Regions
8.4.1 Asia Pacific Oxcarbazepine Sales by Countries
8.4.2 Asia Pacific Oxcarbazepine Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam
9 Central & South America
9.1 Central & South America Oxcarbazepine Breakdown Data by Company
9.2 Central & South America Oxcarbazepine Breakdown Data by Type
9.3 Central & South America Oxcarbazepine Breakdown Data by Application
9.4 Central & South America Oxcarbazepine Breakdown Data by Countries
9.4.1 Central & South America Oxcarbazepine Sales by Countries
9.4.2 Central & South America Oxcarbazepine Revenue by Countries
9.4.3 Brazil
10 Middle East and Africa
10.1 Middle East and Africa Oxcarbazepine Breakdown Data by Type
10.2 Middle East and Africa Oxcarbazepine Breakdown Data by Application
10.3 Middle East and Africa Oxcarbazepine Breakdown Data by Countries
10.3.1 Middle East and Africa Oxcarbazepine Sales by Countries
10.3.2 Middle East and Africa Oxcarbazepine Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa
11 Company Profiles
11.1 Novartis (Trileptal)
11.1.1 Novartis (Trileptal) Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Oxcarbazepine
11.1.4 Oxcarbazepine Product Introduction
11.1.5 Novartis (Trileptal) Recent Development
11.2 Supernus Pharmaceuticals (Oxtellar XR)
11.2.1 Supernus Pharmaceuticals (Oxtellar XR) Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Oxcarbazepine
11.2.4 Oxcarbazepine Product Introduction
11.2.5 Supernus Pharmaceuticals (Oxtellar XR) Recent Development
11.3 Sun Pharm
11.3.1 Sun Pharm Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Oxcarbazepine
11.3.4 Oxcarbazepine Product Introduction
11.3.5 Sun Pharm Recent Development
11.4 Ranbaxy Pharmaceuticals
11.4.1 Ranbaxy Pharmaceuticals Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Oxcarbazepine
11.4.4 Oxcarbazepine Product Introduction
11.4.5 Ranbaxy Pharmaceuticals Recent Development
11.5 Jubilant Generics
11.5.1 Jubilant Generics Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Oxcarbazepine
11.5.4 Oxcarbazepine Product Introduction
11.5.5 Jubilant Generics Recent Development
11.6 Taro Pharmaceuticals
11.6.1 Taro Pharmaceuticals Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Oxcarbazepine
11.6.4 Oxcarbazepine Product Introduction
11.6.5 Taro Pharmaceuticals Recent Development
11.7 Mylan
11.7.1 Mylan Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Oxcarbazepine
11.7.4 Oxcarbazepine Product Introduction
11.7.5 Mylan Recent Development
11.8 Stada Group
11.8.1 Stada Group Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Oxcarbazepine
11.8.4 Oxcarbazepine Product Introduction
11.8.5 Stada Group Recent Development
11.9 Glenmark Pharmaceuticals
11.9.1 Glenmark Pharmaceuticals Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Oxcarbazepine
11.9.4 Oxcarbazepine Product Introduction
11.9.5 Glenmark Pharmaceuticals Recent Development
11.10 ANI Pharmaceuticals
11.10.1 ANI Pharmaceuticals Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Oxcarbazepine
11.10.4 Oxcarbazepine Product Introduction
11.10.5 ANI Pharmaceuticals Recent Development
11.11 Teva Pharmaceutical
11.12 Roxane Laboratories
11.13 Nobelpharma
11.14 Apotex
11.15 Nexgen pharma
11.16 Amneal Pharmaceuticals
11.17 Hikma Pharmaceuticals
11.18 Jamp Pharma
11.19 Neuraxpharm
11.20 Orion Corporation
11.21 Sihuan Pharm
11.22 Humanwell Healthcare
11.23 Huikang Pharmaceutical
12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Oxcarbazepine Sales Channels
12.2.2 Oxcarbazepine Distributors
12.3 Oxcarbazepine Customers
13 Market Forecast
13.1 Global Oxcarbazepine Sales and Revenue Forecast 2019-2025
13.2 Global Oxcarbazepine Sales Forecast by Type
13.3 Global Oxcarbazepine Sales Forecast by Application
13.4 Oxcarbazepine Forecast by Regions
13.4.1 Global Oxcarbazepine Sales Forecast by Regions 2019-2025
13.4.2 Global Oxcarbazepine Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Oxcarbazepine Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Oxcarbazepine Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Oxcarbazepine Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Oxcarbazepine Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Oxcarbazepine Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Figure Oxcarbazepine Product Picture
Table Oxcarbazepine Key Market Segments
Table Major Manufacturers Oxcarbazepine Covered in This Report
Table Global Oxcarbazepine Market Size Growth Rate by Type 2019-2025 (M Unit) & (Million US$)
Figure Global Oxcarbazepine Sales Market Shar by Type 2014-2025
Figure Tablets (150mg, 300mg, 600mg) Figures
Table Major Manufacturers of Tablets (150mg, 300mg, 600mg)
Figure Oral Suspension Figures
Table Major Manufacturers of Oral Suspension
Table Global Oxcarbazepine Market Share by Application 2019-2025 (M Unit)
Figure Pediatric Use (Aged 2-4 years, 4-16 years) Use Case
Figure Adult Use Use Case
Figure Oxcarbazepine Report Years Considered
Figure Global Oxcarbazepine Market Size 2014-2025 (Million US$)
Figure Global Oxcarbazepine Sales 2014-2019 (M Unit)
Table Global Oxcarbazepine Market Size by Regions 2014-2019 (M Unit) & (Million US$)
Table Global Oxcarbazepine Sales by Regions 2014-2019 (M Unit)
Table Global Oxcarbazepine Sales Market Share by Regions 2014-2019
Figure Global Oxcarbazepine Sales Market Share by Regions 2014-2019
Figure Global Oxcarbazepine Sales Market Share by Regions in 2018
Table Global Oxcarbazepine Revenue by Regions 2014-2019 (Million US$)
Table Global Oxcarbazepine Revenue Market Share by Regions 2014-2019
Figure Global Oxcarbazepine Revenue Market Share by Regions 2014-2019
Figure Global Oxcarbazepine Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Oxcarbazepine Sales by Manufacturers (2014-2019) (M Unit)
Table Global Oxcarbazepine Sales Share by Manufacturers (2014-2019)
Figure Global Oxcarbazepine Sales Share by Manufacturers in 2018
Table Oxcarbazepine Revenue by Manufacturers (2014-2019) (Million USD)
Table Oxcarbazepine Revenue Share by Manufacturers (2014-2019)
Figure Oxcarbazepine Value Share by Manufacturers in 2018
Table Global Oxcarbazepine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Oxcarbazepine Price (2014-2019) (USD/Unit)
Table Key Manufacturers Oxcarbazepine Plants/Factories Distribution
Table Key Manufacturers Oxcarbazepine Area Served
Table Date of Key Manufacturers Enter into Oxcarbazepine Market
Table Key Manufacturers Oxcarbazepine Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Tablets (150mg, 300mg, 600mg) Sales an目录输出!D Revenue (2014-2019) (M Unit) & (Million US$)
Table Global Oral Suspension Sales an目录输出!D Revenue (2014-2019) (M Unit) & (Million US$)
Table Global Oxcarbazepine Sales by Type (2014-2019) (M Unit)
Table Global Oxcarbazepine Sales Share by Type (2014-2019)
Figure Global Oxcarbazepine Sales Market Share by Type (2014-2019)
Figure Global Oxcarbazepine Sales Market Share by Type in 2018
Table Global Oxcarbazepine Revenue by Type (2014-2019) (Million US$)
Table Global Oxcarbazepine Revenue Share by Type (2014-2019)
Figure Global Oxcarbazepine Revenue Market Share by Type (2014-2019)
Figure Global Oxcarbazepine Revenue Market Share by Type in 2018
Table Oxcarbazepine Price by Type 2014-2019 (USD/Unit)
Table Global Oxcarbazepine Sales by Application (2014-2019) (M Unit)
Table Global Oxcarbazepine Sales Share by Application (2014-2019)
Figure Global Sales Oxcarbazepine Market Share by Application (2014-2019)
Figure Global Sales Oxcarbazepine Market Share by Application in 2018
Figure North America Oxcarbazepine Sales Growth Rate 2014-2019 (M Unit)
Figure North America Oxcarbazepine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Oxcarbazepine Sales by Company (2014-2019) (M Unit)
Table North America Oxcarbazepine Sales Market Share by Company (2014-2019)
Figure North America Oxcarbazepine Sales Market Share by Company in 2018
Table North America Oxcarbazepine Sales by Type (2014-2019) (M Unit)
Table North America Oxcarbazepine Sales Market Share by Type (2014-2019)
Figure North America Oxcarbazepine Market Share by Type in 2018
Table North America Oxcarbazepine Sales by Application (2014-2019) (M Unit)
Table North America Oxcarbazepine Sales Market Share by Application (2014-2019)
Figure North America Oxcarbazepine Market Share by Application in 2018
Table North America Oxcarbazepine Sales by Countries (2014-2019) (M Unit)
Table North America Oxcarbazepine Sales Market Share by Countries (2014-2019)
Figure North America Oxcarbazepine Sales Market Share by Countries in 2018
Table North America Oxcarbazepine Revenue by Countries (2014-2019) (Million US$)
Table North America Oxcarbazepine Revenue Market Share by Countries (2014-2019)
Figure North America Oxcarbazepine Revenue Market Share by Countries in 2018
Figure United States Oxcarbazepine Sales Growth Rate (2014-2019) (M Unit)
Figure Canada Oxcarbazepine Sales Growth Rate (2014-2019) (M Unit)
Figure Mexico Oxcarbazepine Sales Growth Rate (2014-2019) (M Unit)
Figure Europe Oxcarbazepine Sales Growth Rate 2014-2019 (M Unit)
Figure Europe Oxcarbazepine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Oxcarbazepine Sales by Company (2014-2019) (M Unit)
Table Europe Oxcarbazepine Sales Market Share by Company (2014-2019)
Figure Europe Oxcarbazepine Sales Market Share by Company in 2018
Table Europe Oxcarbazepine Sales by Type (2014-2019) (M Unit)
Table Europe Oxcarbazepine Sales Market Share by Type (2014-2019)
Figure Europe Oxcarbazepine Sales Market Share by Type in 2018
Table Europe Oxcarbazepine Sales by Application (2014-2019) (M Unit)
Table Europe Oxcarbazepine Sales Market Share by Application (2014-2019)
Figure Europe Oxcarbazepine Sales Market Share by Application in 2018
Table Europe Oxcarbazepine Sales by Countries (2014-2019) (M Unit)
Table Europe Oxcarbazepine Sales Market Share by Countries (2014-2019)
Figure Europe Oxcarbazepine Sales Market Share by Countries in 2018
Table Europe Oxcarbazepine Revenue by Countries (2014-2019) (Million US$)
Table Europe Oxcarbazepine Revenue Market Share by Countries (2014-2019)
Figure Europe Oxcarbazepine Revenue Market Share by Countries in 2018
Figure Germany Oxcarbazepine Sales Growth Rate (2014-2019) (M Unit)
Figure France Oxcarbazepine Sales Growth Rate (2014-2019) (M Unit)
Figure UK Oxcarbazepine Sales Growth Rate (2014-2019) (M Unit)
Figure Italy Oxcarbazepine Sales Growth Rate (2014-2019) (M Unit)
Figure Russia Oxcarbazepine Sales Growth Rate (2014-2019) (M Unit)
Figure Asia Pacific Oxcarbazepine Sales Growth Rate 2014-2019 (M Unit)
Figure Asia Pacific Oxcarbazepine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Oxcarbazepine Sales by Regions (2014-2019) (M Unit)
Table Asia Pacific Oxcarbazepine Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Oxcarbazepine Sales Market Share by Regions in 2018
Table Asia Pacific Oxcarbazepine Sales by Type (2014-2019) (M Unit)
Table Asia Pacific Oxcarbazepine Sales Market Share by Type (2014-2019)
Figure Asia Pacific Oxcarbazepine Market Share by Type in 2018
Table Asia Pacific Oxcarbazepine Sales by Application (2014-2019) (M Unit)
Table Asia Pacific Oxcarbazepine Sales Market Share by Application (2014-2019)
Figure Asia Pacific Oxcarbazepine Market Share by Application in 2018
Table Asia Pacific Oxcarbazepine Sales by Countries (2014-2019) (M Unit)
Table Asia Pacific Oxcarbazepine Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Oxcarbazepine Sales Market Share by Regions in 2018
Table Asia Pacific Oxcarbazepine Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific Oxcarbazepine Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific Oxcarbazepine Revenue Market Share by Regions in 2018
Figure China Oxcarbazepine Sales Growth Rate (2014-2019) (M Unit)
Figure China Oxcarbazepine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Oxcarbazepine Sales Growth Rate (2014-2019) (M Unit)
Figure Japan Oxcarbazepine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Oxcarbazepine Sales Growth Rate (2014-2019) (M Unit)
Figure Korea Oxcarbazepine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Oxcarbazepine Sales Growth Rate (2014-2019) (M Unit)
Figure India Oxcarbazepine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Oxcarbazepine Sales Growth Rate (2014-2019) (M Unit)
Figure Australia Oxcarbazepine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Oxcarbazepine Sales Growth Rate (2014-2019) (M Unit)
Figure Indonesia Oxcarbazepine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Oxcarbazepine Sales Growth Rate (2014-2019) (M Unit)
Figure Malaysia Oxcarbazepine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Oxcarbazepine Sales Growth Rate (2014-2019) (M Unit)
Figure Philippines Oxcarbazepine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Oxcarbazepine Sales Growth Rate (2014-2019) (M Unit)
Figure Thailand Oxcarbazepine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Oxcarbazepine Sales Growth Rate (2014-2019) (M Unit)
Figure Vietnam Oxcarbazepine Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America Oxcarbazepine Sales Growth Rate 2014-2019 (M Unit)
Figure Central & South America Oxcarbazepine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Oxcarbazepine Sales by Company (2014-2019) (M Unit)
Table Central & South America Oxcarbazepine Sales Market Share by Company (2014-2019)
Figure Central & South America Oxcarbazepine Sales Market Share by Company in 2018
Table Central & South America Oxcarbazepine Sales by Type (2014-2019) (M Unit)
Table Central & South America Oxcarbazepine Sales Market Share by Type (2014-2019)
Figure Central & South America Oxcarbazepine Market Share by Type in 2018
Table Central & South America Oxcarbazepine Sales by Application (2014-2019) (M Unit)
Table Central & South America Oxcarbazepine Sales Market Share by Application (2014-2019)
Figure Central & South America Oxcarbazepine Market Share by Application in 2018
Table Central & South America Oxcarbazepine Sales by Countries (2014-2019) (M Unit)
Table Central & South America Oxcarbazepine Sales Market Share by Countries (2014-2019)
Figure Central & South America Oxcarbazepine Sales Market Share by Countries in 2018
Table Central & South America Oxcarbazepine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Oxcarbazepine Revenue Market Share by Countries (2014-2019)
Figure Central & South America Oxcarbazepine Revenue Market Share by Countries in 2018
Figure Brazil Oxcarbazepine Sales Growth Rate (2014-2019) (M Unit)
Figure Brazil Oxcarbazepine Revenue Growth Rate (2014-2019) (M Unit)
Figure Middle East and Africa Oxcarbazepine Sales Growth Rate 2014-2019 (M Unit)
Figure Middle East and Africa Oxcarbazepine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Oxcarbazepine Sales by Type (2014-2019) (M Unit)
Table Middle East and Africa Oxcarbazepine Sales Market Share by Type (2014-2019)
Figure Middle East and Africa Oxcarbazepine Sales Market Share by Type in 2018
Table Middle East and Africa Oxcarbazepine Sales by Application (2014-2019) (M Unit)
Table Middle East and Africa Oxcarbazepine Sales Market Share by Application (2014-2019)
Figure Middle East and Africa Oxcarbazepine Sales Market Share by Application in 2018
Table Middle East and Africa Oxcarbazepine Sales by Countries (2014-2019) (M Unit)
Table Middle East and Africa Oxcarbazepine Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Oxcarbazepine Sales Market Share by Countries in 2018
Table Middle East and Africa Oxcarbazepine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Oxcarbazepine Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Oxcarbazepine Revenue Market Share by Countries in 2018
Figure GCC Countries Oxcarbazepine Sales Growth Rate (2014-2019) (M Unit)
Figure GCC Countries Oxcarbazepine Revenue Growth Rate (2014-2019) (M Unit)
Figure Egypt Oxcarbazepine Sales Growth Rate (2014-2019) (M Unit)
Figure Egypt Oxcarbazepine Revenue Growth Rate (2014-2019) (M Unit)
Figure South Africa Oxcarbazepine Sales Growth Rate (2014-2019) (M Unit)
Figure South Africa Oxcarbazepine Revenue Growth Rate (2014-2019) (M Unit)
Table Novartis (Trileptal) Company Details
Table Novartis (Trileptal) Description and Business Overview
Table Novartis (Trileptal) Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis (Trileptal) Oxcarbazepine Sales Growth Rate (2014-2019)
Table Novartis (Trileptal) Oxcarbazepine Sales Market Share in Global Market
Table Novartis (Trileptal) Recent Development
Table Supernus Pharmaceuticals (Oxtellar XR) Company Details
Table Supernus Pharmaceuticals (Oxtellar XR) Description and Business Overview
Table Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales Growth Rate (2014-2019)
Table Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales Market Share in Global Market
Table Supernus Pharmaceuticals (Oxtellar XR) Recent Development
Table Sun Pharm Company Details
Table Sun Pharm Description and Business Overview
Table Sun Pharm Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sun Pharm Oxcarbazepine Sales Growth Rate (2014-2019)
Table Sun Pharm Oxcarbazepine Sales Market Share in Global Market
Table Sun Pharm Recent Development
Table Ranbaxy Pharmaceuticals Company Details
Table Ranbaxy Pharmaceuticals Description and Business Overview
Table Ranbaxy Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Ranbaxy Pharmaceuticals Oxcarbazepine Sales Growth Rate (2014-2019)
Table Ranbaxy Pharmaceuticals Oxcarbazepine Sales Market Share in Global Market
Table Ranbaxy Pharmaceuticals Recent Development
Table Jubilant Generics Company Details
Table Jubilant Generics Description and Business Overview
Table Jubilant Generics Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Jubilant Generics Oxcarbazepine Sales Growth Rate (2014-2019)
Table Jubilant Generics Oxcarbazepine Sales Market Share in Global Market
Table Jubilant Generics Recent Development
Table Taro Pharmaceuticals Company Details
Table Taro Pharmaceuticals Description and Business Overview
Table Taro Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Taro Pharmaceuticals Oxcarbazepine Sales Growth Rate (2014-2019)
Table Taro Pharmaceuticals Oxcarbazepine Sales Market Share in Global Market
Table Taro Pharmaceuticals Recent Development
Table Mylan Company Details
Table Mylan Description and Business Overview
Table Mylan Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mylan Oxcarbazepine Sales Growth Rate (2014-2019)
Table Mylan Oxcarbazepine Sales Market Share in Global Market
Table Mylan Recent Development
Table Stada Group Company Details
Table Stada Group Description and Business Overview
Table Stada Group Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Stada Group Oxcarbazepine Sales Growth Rate (2014-2019)
Table Stada Group Oxcarbazepine Sales Market Share in Global Market
Table Stada Group Recent Development
Table Glenmark Pharmaceuticals Company Details
Table Glenmark Pharmaceuticals Description and Business Overview
Table Glenmark Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Glenmark Pharmaceuticals Oxcarbazepine Sales Growth Rate (2014-2019)
Table Glenmark Pharmaceuticals Oxcarbazepine Sales Market Share in Global Market
Table Glenmark Pharmaceuticals Recent Development
Table ANI Pharmaceuticals Company Details
Table ANI Pharmaceuticals Description and Business Overview
Table ANI Pharmaceuticals Oxcarbazepine Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table ANI Pharmaceuticals Oxcarbazepine Sales Growth Rate (2014-2019)
Table ANI Pharmaceuticals Oxcarbazepine Sales Market Share in Global Market
Table ANI Pharmaceuticals Recent Development
Table Teva Pharmaceutical Company Details
Table Roxane Laboratories Company Details
Table Nobelpharma Company Details
Table Apotex Company Details
Table Nexgen pharma Company Details
Table Amneal Pharmaceuticals Company Details
Table Hikma Pharmaceuticals Company Details
Table Jamp Pharma Company Details
Table Neuraxpharm Company Details
Table Orion Corporation Company Details
Table Sihuan Pharm Company Details
Table Humanwell Healthcare Company Details
Table Huikang Pharmaceutical Company Details
Figure Oxcarbazepine Value Chain
Table Oxcarbazepine Distributors List
Table Oxcarbazepine Customers List
Table Global Oxcarbazepine Sales Forecast 2019-2025 (M Unit) & (Million US$)
Figure Global Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Figure Global Oxcarbazepine Revenue Forecast 2019-2025 (Million US$)
Table Global Oxcarbazepine Sales Forecast by Type 2019-2025 (M Unit)
Figure Global Oxcarbazepine Sales Forecast by Type 2019-2025 (M Unit)
Figure Global Oxcarbazepine Sales Market Share Forecast by Type 2019-2025
Table Global Oxcarbazepine Sales Forecast by Application 2019-2025 (M Unit)
Figure Global Oxcarbazepine Sales Forecast by Application 2019-2025 (M Unit)
Figure Global Oxcarbazepine Sales Market Share Forecast by Application 2019-2025
Table Global Oxcarbazepine Sales Forecast by Regions 2019-2025 (M Unit)
Figure Global Oxcarbazepine Sales Forecast by Regions 2019-2025 (M Unit)
Figure Global Oxcarbazepine Sales Market Share Forecast by Regions 2019-2025
Table Global Oxcarbazepine Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Oxcarbazepine Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Oxcarbazepine Revenue Market Share Forecast by Regions 2019-2025
Table North America Oxcarbazepine Sales Forecast by Countries 2019-2025 (M Unit)
Table North America Oxcarbazepine Sales Market Share Forecast by Countries 2019-2025
Table North America Oxcarbazepine Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America Oxcarbazepine Revenue Market Share Forecast by Countries 2019-2025
Figure United States Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Figure Canada Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Figure Mexico Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Table Europe Oxcarbazepine Sales Forecast by Countries 2019-2025 (M Unit)
Table Europe Oxcarbazepine Sales Market Share Forecast by Countries 2019-2025
Table Europe Oxcarbazepine Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe Oxcarbazepine Revenue Market Share Forecast by Countries 2019-2025
Figure Germany Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Figure France Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Figure UK Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Figure Italy Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Figure Russia Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Table Asia Pacific Oxcarbazepine Sales Forecast by Regions 2019-2025 (M Unit)
Table Asia Pacific Oxcarbazepine Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific Oxcarbazepine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific Oxcarbazepine Revenue Market Share Forecast by Regions 2019-2025
Figure China Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Figure Japan Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Figure South Korea Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Figure India Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Figure Australia Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Figure Indonesia Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Figure Thailand Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Figure Malaysia Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Figure Philippines Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Figure Vietnam Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Table Central & South America Oxcarbazepine Sales Forecast by Countries 2019-2025 (M Unit)
Table Central & South America Oxcarbazepine Sales Market Share Forecast by Countries 2019-2025
Table Central & South America Oxcarbazepine Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America Oxcarbazepine Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Table Middle East and Africa Oxcarbazepine Sales Forecast by Regions 2019-2025 (M Unit)
Table Middle East and Africa Oxcarbazepine Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa Oxcarbazepine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa Oxcarbazepine Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Figure GCC Countries Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Figure Egypt Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Figure South Africa Oxcarbazepine Sales Forecast 2019-2025 (M Unit)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のオキシカルバゼピン産業調査2019-2025 Oxcarbazepine, sold under the brand name Trileptal among others, is a medication used to treat epilepsy and bipolar disorder. It is a structural derivative of carbamazepine, with an extra oxygen atom to the benzylcarboxamide group. The presence of an extra oxygen atom in the structure reduces the su…- 世界のオキシカルバゼピン錠産業調査2019-2025 Oxcarbazepine Tablets, sold under the brand name Trileptal among others, is a medication used to treat epilepsy and bipolar disorder.In 2018, the global Oxcarbazepine Tablets market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2…
- 世界のオキシカルバゼピン錠産業調査2019-2025 Oxcarbazepine Tablets, sold under the brand name Trileptal among others, is a medication used to treat epilepsy and bipolar disorder.In 2018, the global Oxcarbazepine Tablets market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2…
- 世界のオキシカルバゼピンAPI産業調査2019-2025 Oxcarbazepine API (CAS# 28721-07-05 ) is solid and used in anticonvulsant Industry. Oxcarbazepine is an anticonvulsant agent generally used in the treatment of partial seizures in children and adults with epilepsy. It is a structural derivative of carbamazepine, with an extra oxygen atom to the benz…
- 世界のオキシカルバゼピンAPI産業調査2019-2025 Oxcarbazepine API (CAS# 28721-07-05 ) is solid and used in anticonvulsant Industry. Oxcarbazepine is an anticonvulsant agent generally used in the treatment of partial seizures in children and adults with epilepsy. It is a structural derivative of carbamazepine, with an extra oxygen atom to the benz…